Creating a 3D model to develop new treatments for frontotemporal dementia
3D in vitro model of genetic and sporadic FTD: accelerating novel therapeutic development
This study is working on creating a special 3D model of the brain using cells from people with frontotemporal dementia, so researchers can better understand the disease and find new ways to diagnose and treat it.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Synapticure, INC. NIH-funded |
| Lab location | 1 site (Kenilworth, United States) |
| Project ID | NIH-11183885 on NIH RePORTER |
What this research studies
This research focuses on developing a novel 3D in vitro model to better understand and treat frontotemporal dementia (FTD). By using patient-derived cells, the researchers aim to create brain organoids that accurately mimic the disease's characteristics. This model will allow for the testing of new therapies and biomarkers, potentially leading to improved diagnostics and treatment options for patients. The approach seeks to overcome limitations of existing models that have not effectively translated to human applications.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with frontotemporal dementia or those at risk of developing it.
Not a fit: Patients with other forms of dementia unrelated to frontotemporal degeneration may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments and diagnostic tools for patients suffering from frontotemporal dementia.
How similar studies have performed: Previous research using similar 3D organoid models has shown promise in advancing our understanding of neurodegenerative diseases, indicating potential for success in this novel approach.
Where this research is happening
Kenilworth, United States
- Synapticure, INC. — Kenilworth, United States (Active)
Researchers
- Principal investigator: Ghaffari, Layla — Synapticure, INC.
- Study coordinator: Ghaffari, Layla
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.